Stock listing
NASDAQ:GNPX Genprex, Inc. Stock
Home listing (NASDAQ) of Genprex, Inc.
Follow Genprex, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:GNPX
$2.24 USD +0.20 (+9.8%)
Close on Oct 30, 2026
- Day range
- $2.02 – $2.27 USDOct 30, 2026
- Volume
- 164,563 sharesOct 30, 2026
- Market cap
- $1.84M USDAt the close on Oct 30, 2026 · price × 819,709 shares outstanding
- 52-week range
- $1.71 – $138.60 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.01M USDMedian day 113,332 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GNPX · Home | $2.24 USD | +0.20 (+9.8%) | 164,563 | $2.02 | $2.27 | $2.02 | $2.04 | Close on Oct 30, 2026 |
| LSE:0A8I | $1.92 USD | +0.11 (+6.1%) | 124 | $1.89 | $1.92 | $1.75 | $1.81 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:GNPX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.24 | +0.20 | +9.8% | $2.02 | $2.27 | $2.02 | 164,563 | |
| $2.04 | +0.03 | +1.5% | $1.86 | $2.10 | $1.86 | 152,769 | |
| $2.01 | +0.06 | +3.1% | $1.94 | $2.05 | $1.85 | 101,826 | |
| $1.95 | +0.14 | +7.7% | $1.86 | $1.96 | $1.71 | 109,863 | |
| $1.81 | 0.00 | 0.0% | $1.86 | $1.874 | $1.791 | 72,372 | |
| $1.81 | -0.17 | -8.6% | $2.08 | $2.08 | $1.79 | 212,300 | |
| $1.98 | -0.07 | -3.4% | $1.99 | $2.05 | $1.98 | 90,300 | |
| $2.05 | -0.08 | -3.8% | $2.20 | $2.20 | $1.91 | 361,600 | |
| $2.13 | +0.07 | +3.4% | $2.07 | $2.18 | $2.03 | 234,000 | |
| $2.06 | -0.05 | -2.4% | $2.15 | $2.215 | $2.06 | 245,100 | |
| $2.11 | -0.18 | -7.9% | $2.27 | $2.32 | $2.10 | 125,500 | |
| $2.29 | -0.04 | -1.7% | $2.30 | $2.43 | $2.215 | 224,800 | |
| $2.33 | -0.18 | -7.2% | $2.50 | $2.55 | $2.30 | 281,200 | |
| $2.51 | -0.18 | -6.7% | $2.65 | $2.692 | $2.51 | 170,803 | |
| $2.69 | -0.03 | -1.1% | $2.88 | $2.88 | $2.57 | 283,454 | |
| $2.72 | -0.03 | -1.1% | $2.81 | $2.93 | $2.64 | 201,300 | |
| $2.75 | +0.13 | +5.0% | $2.69 | $2.81 | $2.659 | 252,400 | |
| $2.62 | +0.01 | +0.4% | $2.62 | $2.78 | $2.58 | 227,600 | |
| $2.61 | -0.11 | -4.0% | $2.74 | $2.75 | $2.58 | 156,100 | |
| $2.72 | +0.09 | +3.4% | $2.67 | $2.81 | $2.61 | 151,700 | |
| $2.63 | +0.07 | +2.7% | $2.56 | $2.75 | $2.55 | 118,700 | |
| $2.56 | -0.36 | -12.3% | $2.98 | $2.98 | $2.53 | 141,800 | |
| $2.92 | +0.07 | +2.5% | $2.82 | $3.06 | $2.76 | 179,300 | |
| $2.85 | +0.04 | +1.4% | $2.82 | $2.90 | $2.73 | 101,300 | |
| $2.81 | -0.48 | -14.6% | $3.41 | $3.41 | $2.70 | 568,400 | |
| $3.29 | -0.23 | -6.5% | $3.54 | $3.55 | $3.26 | 118,800 | |
| $3.52 | -0.23 | -6.1% | $3.66 | $3.66 | $3.36 | 244,700 | |
| $3.75 | +0.21 | +5.9% | $3.76 | $4.20 | $3.42 | 2,488,700 | |
| $3.54 | +0.06 | +1.7% | $3.54 | $3.60 | $3.47 | 103,800 | |
| $3.48 | +0.03 | +0.9% | $3.48 | $3.65 | $3.46 | 116,800 | |
| $3.45 | -0.01 | -0.3% | $3.45 | $3.60 | $3.37 | 57,500 | |
| $3.46 | +0.05 | +1.5% | $3.50 | $3.58 | $3.34 | 74,300 | |
| $3.41 | +0.10 | +3.0% | $3.35 | $3.41 | $3.26 | 26,800 | |
| $3.31 | -0.14 | -4.1% | $3.45 | $3.475 | $3.30 | 25,600 | |
| $3.45 | +0.10 | +3.0% | $3.35 | $3.569 | $3.35 | 43,200 | |
| $3.35 | 0.00 | 0.0% | $3.39 | $3.43 | $3.33 | 27,700 | |
| $3.35 | -0.08 | -2.3% | $3.38 | $3.44 | $3.31 | 28,800 | |
| $3.43 | -0.11 | -3.1% | $3.54 | $3.57 | $3.361 | 25,900 | |
| $3.54 | +0.04 | +1.1% | $3.47 | $3.65 | $3.42 | 28,700 | |
| $3.50 | +0.075 | +2.2% | $3.60 | $3.605 | $3.387 | 37,200 | |
| $3.425 | -0.085 | -2.4% | $3.52 | $3.57 | $3.37 | 48,400 | |
| $3.51 | -0.04 | -1.1% | $3.51 | $3.61 | $3.49 | 40,000 | |
| $3.55 | -0.16 | -4.3% | $3.62 | $3.64 | $3.46 | 41,300 | |
| $3.71 | +0.04 | +1.1% | $3.73 | $3.84 | $3.63 | 40,700 | |
| $3.67 | +0.06 | +1.7% | $3.68 | $3.75 | $3.63 | 55,600 | |
| $3.61 | -0.36 | -9.1% | $3.95 | $4.02 | $3.57 | 194,500 | |
| $3.97 | -0.03 | -0.7% | $3.99 | $4.07 | $3.93 | 28,000 | |
| $4.00 | -0.02 | -0.5% | $4.02 | $4.17 | $3.951 | 71,700 | |
| $4.02 | +0.07 | +1.8% | $4.02 | $4.12 | $3.936 | 53,200 | |
| $3.95 | 0.00 | 0.0% | $3.90 | $4.289 | $3.86 | 96,100 | |
| $3.95 | -0.04 | -1.0% | $3.99 | $4.05 | $3.88 | 71,600 | |
| $3.99 | +0.04 | +1.0% | $3.86 | $4.16 | $3.85 | 212,200 | |
| $3.95 | -0.525 | -11.7% | $4.24 | $4.83 | $3.83 | 4,292,400 | |
| $4.475 | +0.155 | +3.6% | $4.20 | $4.892 | $4.06 | 446,700 | |
| $4.32 | -0.55 | -11.3% | $4.92 | $4.92 | $4.255 | 90,700 | |
| $4.87 | +0.14 | +3.0% | $4.69 | $5.237 | $4.68 | 103,600 | |
| $4.73 | +0.26 | +5.8% | $4.43 | $4.85 | $4.251 | 73,500 | |
| $4.47 | +0.28 | +6.7% | $4.06 | $4.74 | $4.06 | 158,200 | |
| $4.19 | -0.08 | -1.9% | $4.46 | $4.575 | $4.02 | 119,200 | |
| $4.27 | -0.17 | -3.8% | $4.31 | $4.474 | $4.24 | 77,600 | |
| $4.44 | 0.00 | 0.0% | $4.45 | $4.55 | $4.00 | 148,100 | |
| $4.44 | +0.02 | +0.5% | $4.24 | $4.56 | $4.15 | 106,200 | |
| $4.42 | -0.33 | -6.9% | $4.68 | $4.94 | $4.11 | 409,100 | |
| $4.75 | -1.24 | -20.7% | $5.06 | $5.458 | $4.65 | 2,817,900 | |
| $5.99 | -0.07 | -1.2% | $6.02 | $6.256 | $5.63 | 29,000 | |
| $6.06 | -1.06 | -14.9% | $7.16 | $7.16 | $5.945 | 40,400 |
- Ticker
- NASDAQ:GNPX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
Latest deck · Jul 14, 2026
Investor Presentation (July 2026)
Investor deck · 66 slides
Latest news
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
Oct 28, 2026
Closed $2.01 (+3.1%) on Oct 28, 2026
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
Oct 21, 2026
Closed $2.05 (-3.8%) on Oct 21, 2026
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $3.54 (+1.1%) on Sep 8, 2026
Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program
Sep 1, 2026
Closed $3.55 (-4.3%) on Sep 1, 2026
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
Aug 18, 2026
Closed $3.95 (-11.7%) on Aug 18, 2026
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
Aug 3, 2026
Closed $4.75 (-20.7%) on Aug 3, 2026
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer
Jun 22, 2026
Closed $12.10 (-7.1%) on Jun 22, 2026
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
May 26, 2026
Closed $16.98 (-6.0%) on May 26, 2026
Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
Apr 30, 2026
Closed $21.45 (+12.1%) on Apr 30, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 66 slides · Jul 14, 2026
Investor Presentation (April 2026)
Investor deck · 64 slides · Apr 21, 2026
Investor Presentation (January 2026)
Investor deck · 64 slides · Jan 7, 2026
Investor Presentation (October 2025)
Investor deck · 62 slides · Oct 17, 2025
Genprex, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 126 in all · newest Oct 28, 2026 · oldest 2019
- Decks
- 26 decks · latest Jul 14, 2026
Where Genprex, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GNPX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:GNPX | BOATS | United States | USD |
| Frankfurt:2DE | Frankfurt | Germany | EUR |
| LSE:0A8I | LSE | United Kingdom | USD |
| gettex:2DE | gettex | Germany | EUR |
| Munich:2DE | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Genprex, Inc.